Self-Criticism Feasibility Study
Launched by KING'S COLLEGE LONDON · Jul 10, 2017
Trial Information
Current as of June 05, 2025
Completed
Keywords
ClinConnect Summary
The intervention is based upon recent unpublished doctoral research that developed this novel treatment within students with high levels of self-criticism. This pilot study aims to adapt the intervention for an Improving Access to Psychological Therapies (IAPT) service, a primary mental-health service in the UK.
Self-criticism is a transdiagnostic process across common mental-health disorders and is therefore, a potential target for psychological intervention. Clients at IAPT are likely to present with high levels of self-criticism. This pilot study may help develop an alternative evidence...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Written informed consent
- • 2. Registered with and opt into the Southwark IAPT service, Talking Therapies Southwark
- • 3. Score at least 10 on the WSAS questionnaire regarding the impact of self-criticism on their daily life
- • 4. Requesting help for their self-criticism.
- Exclusion Criteria:
- • 1. Not being sufficiently proficient in English to fully participate in the sessions with English-speaking therapists or process the written study materials for any reason.
- • 2. Being unable to attend six sessions of assessment/treatment.
- • 3. Presenting with high levels of risk requiring monitoring and assistance beyond the weekly intervention focusing on self-criticism.
- • 4. Current serious mental health problem such as bipolar disorder, anorexia nervosa or a moderate / severe substance use disorder.
- • 5. Cognitive impairment or psychomotor retardation of a degree that would prevent completion of the study treatment protocol with the individual. This would be based on a clinical judgement by potential referrers or by the clinician undertaking the screening assessment.
- • 6. Currently experiencing a degree of life stress (e.g. recent bereavement) that is judged by the assessor to be likely to seriously adversely affect their ability to benefit from the intervention
- • 7. New pharmacological interventions for psychological distress - i.e. a change of medication or dosage in the last 4 weeks.
- • 8. Current participation in another clinical (talking therapy or drug) trial or another psychological intervention.
About King's College London
King's College London is a prominent research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the college leverages its extensive expertise in medicine, neuroscience, and public health to conduct rigorous studies aimed at improving patient outcomes. As a sponsor of clinical trials, King's College London prioritizes ethical standards, participant safety, and scientific integrity, fostering an environment that encourages groundbreaking research and the translation of findings into clinical practice. Through its state-of-the-art facilities and a diverse network of researchers, the institution strives to address critical health challenges and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Mehul Elliott-Joshi
Principal Investigator
Institute of Psychiatry, Psychology and Neuroscience (IoPPN), Kings College London; South London and Maudsley (SLaM) NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials